- Tytuł:
- Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial
- Autorzy:
- Źródło:
- In Lung Cancer April 2024 190
Czasopismo naukowe